An integrated clinicopathological and genomic model for personalized prognosis in stage II-III colorectal cancer: a real-world study
{{output}}
Background: The prognosis for patients with stage II-III colorectal cancer (CRC) is heterogeneous, with only a subset benefiting from adjuvant chemotherapy. Currently, prognostic models that effectively integrate clinicopathologi... ...
